title: RIG-I is a tumor suppressor and biomarker of IFN-α efficacy in HCC.
abstract: RIG-I inhibits HCC carcinogenesis and enhances patient survival and IFN-α treatment response.
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000378:metabolism*; D053487:DEAD-box RNA Helicases / Q000378:metabolism*; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000378:metabolism*; D008297:Male
chemical_list: D000970:Antineoplastic Agents; D016898:Interferon-alpha; D053487:DEAD-box RNA Helicases